Longevity Medicine
What Is Sleep Apnea and Longevity?
Last reviewed: May 2026 · Haute MD Editorial Team
Sleep apnea — most commonly obstructive sleep apnea (OSA) — is repeated airway collapse during sleep producing intermittent hypoxia, fragmented sleep architecture, and chronic sympathetic activation. It affects an estimated 25% of middle-aged men and 10% of middle-aged women, the majority undiagnosed. Untreated, it is among the most powerful reversible drivers of hypertension, atrial fibrillation, type 2 diabetes, stroke, dementia, and early mortality.
What sleep apnea does to the body
During an apnea event, the upper airway collapses, oxygen saturation falls (sometimes to 70-80%), CO2 rises, and the brain partially arouses to restore airway patency. These cycles can occur 5-60+ times per hour. Consequences include: chronic intermittent hypoxia (driving oxidative stress and endothelial dysfunction), suppressed deep sleep and REM (impairing memory and metabolic recovery), nocturnal sympathetic surges (elevating blood pressure even during sleep), insulin resistance, elevated inflammation, atrial fibrillation risk increased 2-4x, and stroke risk increased 2-3x. Untreated severe OSA approximately triples all-cause mortality risk over 10-15 years compared to matched controls. It is causally linked to refractory hypertension and is now considered a major modifiable risk factor for dementia.
Who has it and how to diagnose it
Classic risk factors include male sex, age over 40, BMI over 30, large neck circumference (>17 inches in men, >16 in women), hypertension, atrial fibrillation, and craniofacial anatomy with narrow airway. Symptoms include loud snoring, witnessed apneas, daytime sleepiness, morning headache, nocturia, and refractory hypertension — but many patients have minimal subjective symptoms and are still at high cardiovascular risk. Diagnosis is by in-lab polysomnography (gold standard) or home sleep apnea testing (HSAT) — both measure the apnea-hypopnea index (AHI). AHI 5-14 is mild, 15-29 moderate, ≥30 severe. Increasingly, longevity-focused practices screen everyone with adult cardiometabolic risk, since prevalence in undiagnosed asymptomatic adults is high.
Treatment and its effect on longevity
First-line treatment is continuous positive airway pressure (CPAP) — a mask that pneumatically splints the airway open. CPAP reliably normalizes oxygen saturation, restores sleep architecture, lowers blood pressure (often 5-10 mmHg in hypertensive OSA), reduces atrial fibrillation recurrence, improves insulin sensitivity, and reduces cardiovascular events in adherent users. Adherence is the main challenge — modern devices and masks have improved tolerance substantially. Alternatives include mandibular advancement devices (effective for mild-moderate OSA), positional therapy (for positional OSA), weight loss (often produces large reductions in AHI), and hypoglossal nerve stimulation (Inspire device) for selected CPAP-intolerant patients. Anatomical surgery is more rarely indicated. Newer pharmacologic approaches (combination atomoxetine-aroxybutynin) show promise but are not yet first-line. Treating apnea is among the highest-yield single interventions in middle-aged longevity medicine.
Frequently Asked Questions
Can I have sleep apnea if I'm not overweight?
Yes — roughly a third of OSA patients have BMI under 30. Craniofacial anatomy (recessed jaw, narrow palate), tongue size, and age-related airway tissue changes drive non-obese OSA, particularly common in Asian populations and post-menopausal women.
How do I know if I should be tested?
Anyone with loud snoring, witnessed apneas, daytime sleepiness, refractory hypertension, atrial fibrillation, type 2 diabetes, or stroke history should be tested. Many longevity-focused practices screen all middle-aged adults regardless of symptoms given high undiagnosed prevalence.
Is CPAP really worth it?
For moderate-severe OSA, yes — the evidence for cardiovascular and metabolic benefit in adherent users is strong. The bigger barrier is adherence. Modern auto-titrating devices, heated humidification, and modern mask designs have substantially improved tolerance compared to older units.
Does weight loss cure sleep apnea?
Often dramatically improves it, particularly for AHI changes of 10-30% per 10% body weight lost. Some patients can discontinue CPAP after sustained large weight loss, though AHI should be re-measured before doing so, as residual apnea is common even at normal weight.
Get Help Now
Speak with a Haute MD Longevity Medicine physician
Dr. George Kaltner
CEO
Longevity Medicine · Miami Beach, FL
View Profile
Dr. Alexander Golberg
Longevity Medicine · New York, NY
View Profile
Dr. Steven Victor
Regenerative Medicine Specialist
Longevity Medicine · New York, NY
View ProfileAre you a Longevity Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · LONGEVITY MEDICINE
What Is Sleep Architecture?
Sleep architecture is the cyclical pattern of sleep stages — light, deep, and REM — that determines restorative quality. Learn how it shapes longevity.
Read GuideGuide · LONGEVITY MEDICINE
What Is Deep Sleep?
Deep sleep (N3 slow-wave sleep) is the most physically restorative stage, driving hormone release, immune repair, and glymphatic clearance. Learn how to protect it.
Read GuideGuide · LONGEVITY MEDICINE
What Is Heart Rate Variability (HRV)?
Heart rate variability measures beat-to-beat variation in heart rhythm. Learn what HRV reveals about autonomic balance, recovery, and longevity.
Read Guide